Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
Khalil El Karoui(Inserm), Véronique Frémeaux‐Bacchi(Assistance Publique – Hôpitaux de Paris), Florent Petitprez(Inserm), Idris Boudhabhay(Université Paris Cité), Marie Matignon(Inserm), Paula Vieira‐Martins(Assistance Publique – Hôpitaux de Paris), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Florence Aulagnon(Hôpital Necker-Enfants Malades), Fádi Fakhouri(University Hospital of Lausanne), Julien Zuber(Délégation Paris 5), Laurent Mesnard(Sorbonne Université), Éric Rondeau(Centre de Recherche en Automatique de Nancy)
Cited by 61
Related Papers
Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations
|Journal of the American Society of Nephrology|2010|470
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
|American Journal of Transplantation|2013|269
Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients
|Science Translational Medicine|2015|232